FY2025 · period end Dec '25 · from the 10-K filed Feb 9, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $26.98B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000062709-26-000167 | Jun 2, 2026 | Jun 4, 2026 | Jun 3, 2026 21:32 UTC | EDGAR |
| 8-K | 0000062709-26-000128 | May 21, 2026 | May 22, 2026 | May 22, 2026 20:02 UTC | EDGAR |
| 8-K | 0000062709-26-000096 | Apr 16, 2026 | Apr 16, 2026 | Apr 16, 2026 11:02 UTC | EDGAR |
| 10-Q | 0000062709-26-000098 | Mar 31, 2026 | Apr 16, 2026 | Apr 16, 2026 12:11 UTC | EDGAR |
| 8-K | 0000950103-26-005674 | Apr 8, 2026 | Apr 14, 2026 | Apr 14, 2026 12:22 UTC | EDGAR |
| 8-K | 0000062709-26-000071 | Mar 10, 2026 | Mar 10, 2026 | Mar 10, 2026 12:34 UTC | EDGAR |
| 8-K | 0000062709-26-000035 | Feb 25, 2026 | Feb 25, 2026 | Feb 25, 2026 21:02 UTC | EDGAR |
| 8-K | 0001193125-26-059544 | Feb 19, 2026 | Feb 19, 2026 | Feb 19, 2026 21:37 UTC | EDGAR |
Direct links to SEC EDGAR. MRSH has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Operating Income (Loss)·FY 2008
Major restatementwas$248M
Revised up in a 10-K.
Operating Income (Loss)·FY 2009
Major restatementwas$509M
Revised up in a 10-K.
Assets·As of Dec 31, 2022
Major restatementwas$33.5B
Revised up in a 10-K.
Assets·As of Dec 31, 2021
Major restatementwas$34.4B
Revised up in a 10-K.
Operating Income (Loss)·FY 2007
Major restatementwas$854M
Revised down in a 8-K.
Operating Income (Loss)·Q3 2017
Major restatementwas$597M
Revised down in a 10-K.
MRSH is not the only one.
See every restatement we've found across the market — or get an alert the next time MRSH revises a number.
Restatements are detected by comparing every vintage of a fact across all of MARSH & MCLENNAN COMPANIES, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows MRSH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling MARSH & MCLENNAN COMPANIES, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on MRSH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on MRSH and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $22.74B |
| $20.72B |
| $19.82B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $6.22B | $5.82B | $5.28B | $4.28B | $4.31B |
|---|
| Net Income | $4.16B | $4.06B | $3.76B | $3.05B | $3.14B |
|---|
| EPS (Diluted) | $8.48 | $8.31 | $7.39 | $6.06 | $6.20 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $58.71B | $56.48B | $48.03B | $44.11B | $44.01B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $15.31B | $13.54B | $12.37B | $10.75B | $11.22B |
| Cash & Equivalents | $2.69B | $13.67B | $3.36B | $12.10B | $11.37B |
| Total Debt | — | — | — | $11.23B | $10.93B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.29B | $4.30B | $4.26B | $3.46B | $3.52B |
| Capital Expenditures | $0.29B | $0.32B | $0.42B | $0.47B | $0.41B |
| Free Cash Flow | $5.00B | $3.99B | $3.84B | $3.00B | $3.11B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.2% | 0.2% | 0.2% | 0.1% | 0.2% |
| Return on Equity | 28.8% | 31.3% | 32.5% | 27.8% | 30.7% |
| Return on Assets | 7.2% | 7.8% | 8.2% | 6.9% | 8.2% |
| Debt / Equity | 1.36× | 1.51× | 1.22× | 1.04× | 0.97× |
